A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus

Abstract

The utility of flow mediated dilation (FMD) a measure of endothelial function is limited by operator dependence. Pulse amplitude tonometry (PAT) is a novel, less operator-dependent technique to assess endothelial function. This study compares PAT to FMD in SLE and controls. Thirty women with SLE and 31 controls were enrolled. Medications, cardiovascular disease and risk factors, SLE activity (SLAM-R) and damage (SLICC-DI) were recorded. FMD and PAT were performed simultaneously. Endothelium-independent function was assessed with nitroglycerin. Average age was 48.3 ± 10.1 years, SLE duration 16.2 years, SLAM-R 8.3 and SLICC-DI 1.0. Framingham Risk Scores were ≤2% in most subjects. There were no differences between SLE cases and controls in FMD, PAT or response to nitroglycerin. This study found no association between FMD and PAT in SLE or controls. In the 17 SLE cases with a history of Raynaud’s, correlation between FMD and PAT was 0.50 (P = 0.04). There was no difference in endothelial function assessed by FMD or PAT in SLE cases versus controls. FMD did not correlate with PAT except in SLE cases with a history of Raynaud’s. Correlation between FMD and PAT may be stronger in populations with greater variation in endothelial function and more cardiovascular risk factors.

Keywords

atherosclerosis brachial artery (ultrasonography)endothelium vascular (ultrasonography)humans systemic lupus erythematosus vasodilation

Get full access to this article

View all access options for this article.

References

1 Roman MJ Shanker BA Davis A . Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399–2406.

2 Manzi S Meilahn EN Rairie JE . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408–415.

3 Esdaile JM Abrahamowicz M Grodzicky T . Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331–2337.

4 Lee AB Godfrey T Rowley KG . Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J 2006; 36: 237–243.

5 Widlansky ME Gokce N Keaney JF Vita JA . The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149–1160.

6 Johnson SR Harvey PJ Floras JS . Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus 2004; 13: 590–593.

7 Lima DS Sato EI Lima VC Miranda F Hatta FH . Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 292–297.

8 El-Magadmi M Bodill H Ahmad Y . Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399–404.

9 Piper MK Raza K Nuttall SL . Impaired endothelial function in systemic lupus erythematosus. Lupus 2007; 16: 84–88.

10.

10 Nohria A Gerhard-Herman M Creager MA Hurley S Mitra D Ganz P . Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101: 545–548.

11.

11 Kuvin JT Patel AR Sliney KA . Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146: 168–174.

12.

12 Kuvin JT Mammen A Mooney P Alsheikh-Ali AA Karas RH . Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med 2007; 12: 13–16.

13.

13 Bonetti PO Pumper GM Higano ST Holmes DR Kuvin JT Lerman A . Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137–2141.

14.

14 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

15.

15 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

16.

16 Brilli S Tousoulis D Antoniades C . Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta. J Am Coll Cardiol 2008; 51: 742–749.

17.

17 Karlson EW Sanchez-Guerrero J Wright EA . A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995; 5: 297–302.

18.

18 Liang MH Socher SA Roberts WN Esdaile JM . Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988; 31: 817–825.

19.

19 Gladman D Ginzler E Goldsmith C . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

20.

20 Sullivan LM Massaro JM D'Agostino RB . Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004; 23: 1631–1660.

21.

21 Corretti MC Anderson TJ Benjamin EJ . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–265.

22.

22 Uehata A Lieberman EH Gerhard MD . Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med 1997; 2: 87–92.

23.

23 Bonetti PO Barsness GW Keelan PC . Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761–1768.

24.

24 Wright SA O'Prey FM Rea DJ . Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 2006; 26: 2281–2287.

25.

25 Wright SA; O'Prey FM; McHenry MT; . A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 841–848.

26.

26 Vogel RA Corretti MC Plotnick GD . A comparison of brachial artery flow-mediated vasodilation using upper and lower arm arterial occlusion in subjects with and without coronary risk factors. Clin Cardiol 2000; 23: 571–575.

27.

27 Mannion TC Vita JA Keaney JF Benjamin EJ Hunter L Polak JF . Non-invasive assessment of brachial artery endothelial vasomotor function: the effect of cuff position on level of discomfort and vasomotor responses. Vasc Med 1998; 3: 263–267.